Your browser doesn't support javascript.
loading
Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Zhu, Xiao-Dong; Huang, Cheng; Shen, Ying-Hao; Xu, Bin; Ge, Ning-Ling; Ji, Yuan; Qu, Xu-Dong; Chen, Lingli; Chen, Yi; Li, Mei-Ling; Zhu, Jin-Jin; Tang, Zhao-You; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan.
  • Zhu XD; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Huang C; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shen YH; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xu B; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ge NL; Department of Hepatic Oncology, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ji Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qu XD; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen L; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen Y; Department of Hepatic Oncology, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li ML; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhu JJ; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tang ZY; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhou J; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Fan J; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China.
  • Sun HC; Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China. sun.huichuan@zs-hospital.sh.cn.
Ann Surg Oncol ; 30(5): 2782-2790, 2023 May.
Article en En | MEDLINE | ID: mdl-36178565
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article